Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Artículo científico |
| Sprache: | en |
| Veröffentlicht: |
Sociedade Brasileira de Geriatria e Gerontologia
2023
|
| Schlagworte: | |
| Online-Zugang: | https://www.redalyc.org/articulo.oa?id=739777812027 https://www.redalyc.org/journal/7397/739777812027/ https://www.redalyc.org/journal/7397/739777812027/html/ https://www.redalyc.org/journal/7397/739777812027/739777812027.epub https://www.redalyc.org/journal/7397/739777812027/movil https://doi.org/10.53886/gga.e0230015 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Inhaltsangabe:
- Safety assessment of medicines available in the ‘Brazilian list of essential medicines’ in the older persons according to the Beers Criteria Francelle Adorno Sôffa Guimarães Monteiro Gabriela Mesquita Pontes Gilsiane de Sousa Sampaio Maria Eugênia Ribeiro Carvalho de Oliveira Paulo Marcelo de Andrade Lima Multidisciplinaria (Ciencias Naturales y Exactas) aged rename polypharmacy Beers criteria potentially inappropriate medication list Objective: To describe the safety of medicines available in the “Brazilian List of Essential Medicines” (RENAME/2022) for the main comorbidities that affect older persons according to the Beers criteria 2019. Methods: Medicines listed in RENAME and recommended by the respective Brazilian medical guidelines for the treatment of hypertension, heart failure, diabetes, and neurological/ psychiatric diseases were evaluated for their safety profiles according to the Beers criteria 2019. Results: Fifty-eight out of 529 medicines in RENAME were evaluated. Of these, 29 were included in any of the Beers criteria: 20 were classified as potentially inappropriate, 17 should be avoided due to disease exacerbation, and 14 needed to be used with caution. Considering drugs used to treat cardiovascular, diabetes, and neurological/psychiatric disorders, 40.00, 37.50 and 60.00% respectively, had some criterion for their appropriate use in older persons. Conclusion: RENAME presents alternatives for the safe treatment of older patients. In the treatment of cardiovascular diseases, diabetes, and neurodegenerative diseases, the firstchoice recommendations are available in RENAME. Regarding psychiatric disorders, safe pharmacological alternatives are still scarce and need to be better discussed. 2023 artículo científico 2447-2115 https://www.redalyc.org/articulo.oa?id=739777812027 https://www.redalyc.org/journal/7397/739777812027/ https://www.redalyc.org/journal/7397/739777812027/html/ https://www.redalyc.org/journal/7397/739777812027/739777812027.epub https://www.redalyc.org/journal/7397/739777812027/movil https://doi.org/10.53886/gga.e0230015 en http://www.redalyc.org/revista.oa?id=7397 Geriatrics, Gerontology and Aging application/pdf Sociedade Brasileira de Geriatria e Gerontologia Geriatrics, Gerontology and Aging (Brasil) Vol.17